The controversy behind PrEP: Part 3 of our four-part series


HIV News LogoIs PrEP’s promise too good to be true?
In the third part of our series on pre-exposure prophylaxis (PrEP), Daily Xtra looks at the controversy surrounding the HIV prevention drug. While many people are heralding a new chapter in the fight against HIV, others say it’s much too early to claim victory.

In the above video, Nicolas Kazamia speaks with Robert Grant, a senior researcher at the Gladstone Institutes; Alan McCord, from Project Inform; HIV/AIDS prevention workers Tim Ryan and Steve Gibson, from Magnet, a sexual health clinic in San Francisco; and Dale Gluth, the San Francisco Bay area director of the AIDS Healthcare Foundation.

Source...

Advertisements

Share your thoughts

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s